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Background: Inflammation due to remote pathogen exposure combined to hypoxia/ischemia (HI) is one of the
most common causes of neonatal encephalopathy affecting at-term or near-term human newborn, which will
consequently develop cerebral palsy. Within term-equivalent rat brains exposed to systemic lipopolysaccharide
(LPS) plus HI, it was previously showed that neurons produce IL-1β earlier than do glial cells, and that blocking
IL-1 was neuroprotective. To further define the mechanisms whereby IL-1 exerts its neurotoxic effect, we hypothesize
that IL-1β plays a pivotal role in a direct and/or indirect mechanistic loop of neuronal self-injury through matrix
metalloproteinase (MMP)-9.
Methods: An established preclinical rat model of LPS+HI-induced neonatal encephalopathy was used. In situ
hybridization, ELISA, and immunolabeling techniques were employed. Selective blocking compounds allowed
addressing the respective roles of IL-1 and MMP-9.
Results: In LPS+HI-exposed forebrains, neuronal IL-1β was first detected in infarcted neocortical and striatal areas
and later in glial cells of the adjacent white matter. Neuronal IL-1β played a key role: (i) in the early post-HI exacerbation
of neuroinflammation and (ii) in generating both core and penumbral infarcted cerebral areas. Systemically administered
IL-1 receptor antagonist (IL-1Ra) reached the brain and bound to the neocortical and deep gray neuronal membranes.
Then, IL-1Ra down-regulated IL-1β mRNA and MMP-9 neuronal synthesis. Immediately post-HI, neuronal IL-1β
up-regulated cytokine-induced neutrophil chemoattractant (CINC-1), monocyte chemoattractant protein-1
(MCP-1), and inducible nitric oxide synthase. MMP-9 would disrupt the blood–brain barrier, which, combined to
CINC-1 up-regulation, would play a role in polymorphonuclear cell (PMN) infiltration into the LPS+HI-exposed
brain. IL-1β blockade prevented PMN infiltration and oriented the phenotype of macrophagic/microglial cells
towards anti-inflammatory and neurotrophic M2 profile. IL-1β increased the expression of activated caspase-3
and of receptor-interacting-protein (RIP)-3 within infarcted forebrain area. Such apoptotic and necroptotic pathway
activations were prevented by IL-1Ra, as well as ensuing cerebral palsy-like brain damage and motor impairment.
Conclusions: This work uncovered a new paradigm of neuronal self-injury orchestrated by neuronal synthesis of
IL-1β and MMP-9. In addition, it reinforced the translational neuroprotective potential of IL-1 blockers to alleviate
human perinatal brain injuries.
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Hypoxia-ischemia (HI) combined to inflammation is an
important pathophysiological component of neonatal
encephalopathy (NE) affecting up to 1 % of newborns.
Indeed, combined pathogen-induced inflammation com-
plicated by HI was recognized as one of the most com-
mon causes of human perinatal brain damage [1–8].
Moderate and severe forms of NE lead either to death or
lifelong neurodisabilities such as cerebral palsy (CP) or
other neurobehavioral disabilities including learning
difficulties [1, 4]. Combination of inflammation/infection
plus HI has been reproduced experimentally in rodents
at neurodevelopmental stages equivalent to early and
late preterm development of human neonates—i.e., in
rat pups between P1 and P7 [5, 9–13]. Inflammation/in-
fection and HI have also recently been modeled in rats
at a neurodevelopmental stage (P12) corresponding to
full-term human neonate development. Profound differ-
ences in the neuropathological impacts from lipopoly-
saccharide (LPS) plus HI-induced patterns of innate
immune responses have been shown between P1 and
P12 rats [13, 14]. Importantly, these neuropathological
differences reproduce those observed between preterm
and term human newborns [14]. Thus, LPS+HI-induced
brain injury of P12 rat pups is a relevant model for the
study of term human NE [15].
We previously showed that, within term-matched
rat brains exposed to systemic LPS+HI, neurons pro-
duce IL-1β earlier than do glial cells, and that IL-1 re-
ceptor antagonist (IL-1Ra) was neuroprotective [15].
To further define the neurotoxic mechanisms of IL-1
in the immature brain, we hypothesize that IL-1
induces directly and/or indirectly neuronal self-injury
involving matrix metalloproteinase (MMP)-9, blood–




Our pre-clinical model was designed as previously de-
scribed [15]. Briefly, Lewis dams were obtained from
Charles River Laboratories (Saint-Constant, QC, Canada)
between gestational day 14 (G14) and 16 (G16). P12 pups
received a single intraperitoneal (ip) injection of LPS
(200 μg/kg diluted in 50 μL of saline) from Escherichia coli
or saline. Ischemia was induced 4 h after LPS administra-
tion by permanent ligature of the right common carotid
artery followed by 8 % oxygen exposure at 37+/− 1 °C for
1.5 h. A control (Ctl) group underwent no surgery, and a
sham surgery group was submitted to the common
carotid artery exposure without ligature. Because we
found no observable difference in the results of these two
groups, both were combined and identified as the Ctl
group. Pups from each litter were randomized in threedifferent experimental groups (Ctl, LPS+HI, LPS+HI+IL-
1Ra) independently of sex and weight. The end of hypoxia
is referred to as 0 h. Pups were sacrificed at 4 h (P12),
24 h (P13), 48 h (P14), and 8 days (P20) post-HI. Each
session of surgery was performed in groups of 10–20
animals from 2–4 litters; our data of mortality was the
mean ± SEM of mortality from each of these groups (total
of 78 pups in LPS+HI condition; 72 pups in LPS+HI+IL-
1Ra condition; 38 pups in Ctl condition). Some rats were
kept alive until P120 for motor behavior. Rats were eutha-
nized by rapid decapitation. The ethical review board of
the Sherbrooke University approved this experimental
design (protocol #147-11R). The care of animals followed
internationally recognized guidelines.
Blocking experiments using IL-1Ra and MMP-9
inhibitor (SB3CT)
IL-1 receptor antagonist (IL-1Ra) was used at a concen-
tration of 200 mg/kg. This dose has been demonstrated
as the most effective in terms of neuroprotection in
adult stroke models as well as in the above-mentioned
model [15, 16]. The first injection was given ip, 30 min
before LPS injection. Five other injections were given
every 12 h thereafter. SB3CT (Sigma, ON, Canada) was
used at a concentration of 12.5 mg/kg. This dose was
proven effective in a mouse model of middle cerebral
artery occlusion. The first injection was given before sur-
gery, a second 4 h after HI, and another every 12 h
thereafter for a total of six injections.
Histology
Brains were fixed in paraformaldehyde (PFA) 4 % at
room temperature, paraffin-embedded, and cut in 5-μm
slices using a microtome for histological studies.
Hematoxylin-eosin (H&E) staining was used to visualize
and quantify brain injuries. ImageJ analysis software
(National Institutes of Health (NIH) Image, http://
rsbweb.nih.gov/nih-image/) was used to measure the
surface of the right hemisphere on coronal sections
located at the epicenter of the infarct (Bregma −1.00).
The right hemisphere surfaces of LPS- and/or HI-
exposed rats were then compared with those of Ctl. So-
called core vs penumbra areas of brain infarcts were
defined as previously described [15]. Briefly, core injur-
ies were associated with infarcted areas bearing cavitary
lesions, whereas penumbra lesions were identified as
regions surrounding the core where pycnotic neurons
or loss of normal neuronal architecture were observed.
Immunohistochemistry (IHC) and immunofluorescence (IF)
IHC and IF were performed as previously described [5,
15]. Briefly, sections were incubated overnight at 4 °C
with the primary antibodies. The antibodies used are
detailed in Table 1. The appropriate HRP-conjugated or
Table 1 List and features of antibodies
Antibody Company—reference number Dilution
Anti-DIG-AP Roche—11093274910 1:3000














Anti-rabbit-Alexa Fluor conjugated Invitrogen—A11012 1:500
Anti-mouse-Alexa Fluor conjugated Invitrogen—A11005 1:500
Anti-chicken-Alexa Fluor conjugated Invitrogen—A11039 1:500
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each primary Ab and incubated for 1 h at room
temperature. Labeling was revealed using diaminobenzi-
dine (DAB) (Roche, QC, Canada). Slides were counter-
stained with hematoxylin. IF slides were mounted using
a DAPI-containing medium (Invitrogen, ON, Canada).
Negative controls consisted of an additional set of sec-
tions, treated similarly but without the primary antibody.
Labeled cells were counted, and cytokine expression was
analyzed using the ImageJ analysis software (NIH Image,
http://rsbweb.nih.gov/nih-image/). The percentage of
cells meant the number of a given cell type on the total
number of cells per field (magnification ×40).
ELISA
Protein extracts were prepared from right hemisphere
forebrains as previously described [15]. ELISAs were
performed on these protein extracts using ELISA Kits
(R&D System, MN, USA), as previously described [14].
In situ hybridization
mRNA encoding for IL-1β was detected and localized
on brain sections using dioxigenin-UTP (DIG) labeled
riboprobes. The IL-1β DNA template was amplified
using primers with specific restriction enzymes: IL-1β
BamHI forward 5′- AGT CCT GGA TCC ATG GCA
ACT GTC CCT GAA CT -3′ and IL-1β EcoRI reverse
5′- GGC CGC GAA TTC AGC TCA TGG AGA ATA
CCA CT -3′. DIG-labeled single-stranded RNA was
transcribed from commercially available plasmid vectorsaccording to manufacturer instructions (Roche, Laval,
QC, Canada, 1175025). The in situ hybridization proto-
col used was that of Dr Jasna Kriz [17]. Briefly, slides
were dried, post-fixed in 4 % paraformaldehyde, and
digested by proteinase K, after which brain sections were
washed in water, in a solution of 0.1 M triethanolamine
(TEA, pH 8.0), and then acetylated in 0.25 % acetic
anhydride in 0.1 M TEA. Hybridization of brain sections
with the riboprobe was performed overnight at 72 °C.
Slides were washed in standard saline citrate (1XSSC:
0.15 M NaCl, 15 mM trisodium citrate buffer, pH 7.0)
and were then incubated with anti-DIG-AP antibodies
overnight at 4 °C. Next, slides were incubated with
NBT/BCIP solution, for color development; at room
temperature for 16 h. Slides were then washed with
TBST and mounted with DAKO Cytomation Glycergel
Mounting Medium. Staining intensities of IL-1β mRNA
were studied by colorimetric analysis performed with
ImageJ software as previously described [15].
Behavioral tests
Circling behavior test was performed using the open
field test apparatus. Rat pups at P14 were placed in the
center of the open field and videotaped for 1.5 min.
The movements of the pups were scored as following:
0 = absence of circling, 1 = partial circling, 2 = total
circling [15]. The open field test was used to determine
spontaneous locomotor activity and exploratory behavior
from P100 to P120, as described previously [5]. Elevated
body swing test was used, as previously described, to
Fig. 1 (See legend on next page.)
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P120 [18]. The movements of rats suspended by their tails
were video-recorded. We set the threshold at an angle of
90° for an efficient upswing. Latency before the first effi-
cient upswing, the side of the efficient upswing, and thetotal number of efficient upswings were recorded and
compared across experimental conditions. The Turning in
Alley test was performed at P100–P120, as previously
described, to assess any potential persisting shift of
lateralization due to motor impairment [19]. Rats were
(See figure on previous page.)
Fig. 1 Impact of IL-1Ra on the BBB after LPS+HI exposure. Titer (ELISA) of hrIL-1Ra (pg/mg) in the right cerebral hemisphere at 4 and 24 h after
LPS+HI ± IL-1Ra exposure (a). Immunohistochemistry (IHC) staining of hrIL-1Ra associated with neurons (arrowhead) in LPS+HI ± IL-1Ra-exposed
brains at 48 h (b). Relative hrIL-1Ra expression (IHC) at 48 h in LPS+HI ± IL-1Ra-exposed frontoparietal cortical areas compared to control (c).
IL-1Ra prevented albumin (IHC staining) entry within the brain at 48 h (d). IL-1Ra decreased IHC relative expression of albumin in the right
cerebral hemispheres 48 h after LPS+HI exposure (e). IL-1Ra prevented LPS+HI-induced BBB disruption (loss of linear co-localization of GFAP
and claudin-5 (arrowheads)) as seen by confocal microscopy following immunofluorescent (IF) staining of claudin-5 and GFAP of blood vessels
of right frontoparietal middle neocortical blood vessels of LPS+HI ± IL-1Ra-exposed rats at 4 h post-HI (f). IF images are representative of the
blood vessels in damaged areas. Error bars represent means ± SEM, scale bar = 10 μm, three to six animals per conditions, unpaired t test with
Welch correction, * p ≤ 0.05, *** p ≤ 0.001, **** p ≤ 0.0001. Abbreviations: GFAP glial fibrillary acidic protein, Clau5 claudin-5
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the side of the turning were recorded.
Data analysis
Data are presented as means ± SEM. Results across
experimental conditions were compared using the un-
paired t test with Welch correction. The statistical
significance level was set at p ≤ 0.05. Data from the
Ctl group and sham group were combined, as well as
male and female data, because they are not signifi-
cantly different.
Results
Distribution of IL-1Ra in LPS+HI-exposed brains
hrIL-1Ra (ip injected) crossed the blood–brain barrier
(BBB), bound to neurons (Fig. 1a–c), and rapidly
reached a high intracerebral titer (above 2500 pg/mg) at
4 h and 24 h post HI in brains exposed to LPS+HI+IL-
1Ra condition (Fig. 1a). To test whether the BBB might
be permeated by an LPS+HI insult, as well as its pre-
ventability by IL-1Ra, we looked for an albumin leakage
through the forebrain BBB at 4 h and 48 h post-HI ± IL-
1Ra. A functional disruption of BBB in LPS+HI condi-
tion and its prevention by IL-1Ra was demonstrated by
a significantly higher albumin infiltration in LPS+HI
than in LPS+HI+IL-1Ra exposed brains (Fig. 1d, e). A
structural disruption of BBB was also shown in LPS+HI-
exposed brains at 4 h after post-LPS+HI (Fig. 1f): LPS+HI
exposure disrupted the tight junction protein claudin-
5 and GFAP linear/continuous expression of BBB. IL-
1Ra prevented the disruptive effect of LPS+HI on the
BBB (Fig. 1f ).
To test whether IL-1Ra immunoreactivity detected at
the surface of neurons might interfere with IL-1 func-
tion, we compared the levels of auto-activation of IL-1β
synthesis between LPS+HI vs LPS+HI+IL-1Ra condi-
tions (Fig. 2a–f ). Compared to LPS+HI alone, forebrains
exposed to LPS+HI+IL-1Ra presented a two to threefold
drop in IL-1β mRNA (in situ hybridization) at 1 h post-
HI (Fig. 2e) and in IL-1β expression (ELISA) at 24 h and
48 h post-HI (Fig. 2a). This IL-1β synthesis and its drop
under IL-1Ra treatment was from neuronal cells as
shown by in situ hybridization at 1 h post-HI (Fig. 2d, e)
and by IHC in both core and penumbra at 4 h post-HI(Fig. 2c). IL-1Ra binding to neurons was shown by IF
(NeuN+IL-1Ra+) double labeling at 4 h post-HI (Fig. 2f ).
The discrepancy between the diminished IL-1β detection
on neuronal cell bodies by IHC at 4 h (Fig. 2c) and its
absence of decrease at the same time by ELISA (Fig. 2a)
might be due to the rapid binding of IL-1Ra on the
neuronal IL-1Rs that would limit other IL-1 ligands
binding at 4 h but without any decrease in the amount
of free extracellular IL-1 at this early—but not later—-
time points (Fig. 2a, c).IL-1Ra protects against LPS+HI-induced brain injury and
ensuing neurobehavioral morbidity and mortality
IL-1Ra reduced LPS+HI-induced mortality (Fig. 3a). The
comparison of H&E staining between brains exposed to
LPS+HI vs LPS+HI+IL-1Ra showed that IL-1Ra pre-
vented the extent of brain injury (Fig. 3b, c). IL-1Ra
exerted a neuroprotective effect on both the core and
penumbra components of ischemic gray and WM injur-
ies of the forebrain (Fig. 3b, c). Behavioral experiments
showed that LPS+HI-induced motor impairment was
prevented by IL-1Ra at both early juvenile (P14) and late
adult (P120) time points (Fig. 4). This curbing of brain
injury, and subsequent motor behavior impairment, was
associated with an early drop of neuronal IL-1β mRNA
expression within the infarcted area, from 1 h post-LPS
+HI (Fig. 2d, e). This intra-cerebral drop in IL-1β mRNA
and IL-1β synthesis under IL-1Ra treatment might result
from decreased activation of either neuronal nuclear
factors e.g. NF-κB, or nod-like receptors (NLRs) of the
inflammasome, or both. It has previously been shown
that the inflammasome is activated during adult brain
injury and that NLRP1 and NLRP3 (NLRs) are detected
in adult neurons and macrophage/microglia, respect-
ively [20]. Our results showed that NLRP1 and NLRP3
remained undetectable at P1, but that NLRP1 start to
be expressed in cortical and subcortical neurons at P12
(Fig. 5a); 50 % of NLRP1+ cells we observed at P12
were also NeuN+; thus, glial cells at this P12 stage of
development in rats also expressed NLRP1. NLRP3 was
not detected at P1 or P12, but was at P40 in macro-
phage/microglial cells though not in neurons (Fig. 5b).
This means that NLRP1 driven inflammasome might
Fig. 2 Effect of IL-1Ra on IL-1β in LPS+HI-exposed brains. IL-1Ra decreased titers (ELISA) of IL-1β (pg/mg) at 24 and 48 h following LPS+HI
exposures (a). IL-1Ra decreased IL-1β relative IHC expressions in the right frontoparietal neocortex, white matter (WM), and striatum at 4 h
after LPS+HI exposures (b). IL-1Ra prevented IHC staining of IL-1β in the neocortex of LPS+HI-exposed pups at 4 h post-HI (c). IL-1Ra prevented neuronal
IL-1β mRNA expression (arrowhead) in the neocortex 1 h after LPS+HI as detected by in situ hybridization (d). IL-1Ra decreased relative expression of IL-1β
mRNA in right frontoparietal cortical neurons 1 h post LPS+HI (e). IF double staining of NeuN+IL-1Ra+ neurons at 4 h post-HI in LPS+HI+IL-1Ra condition
(f). Error bars represent means ± SEM, scale bar = 10 μm, four to six animals per conditions, unpaired t test with Welch correction, * p ≤ 0.05,
** p ≤ 0.01, *** p ≤ 0.001. Abbreviations: WM white matter
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IL-1β release.
IL-1Ra interferes with key neuroinflammatory mediators
and prevents LPS+HI-induced PMN recruitment and
amoeboid M1 pro-inflammatory polarization of
macrophage/microglia
IL-1Ra prevented PMN infiltration within LPS+HI-exposed
brains at 48 h (Fig. 6a, b). IL-1Ra also curbed the inductionof IL-1β-driven PMN-recruiting chemokine CINC-1
(cytokine-induced neutrophil chemoattractant-1) at 4
and 24 h—by respectively threefold and twofold—
within the LPS+HI injured forebrain (Fig. 6c, d).
IL-1Ra had no effect on the total number of macro-
phage detected within LPS+HI injured brain areas
(Fig. 7a). The proportion of inducible nitric oxide
synthase (iNOS) positive cells significantly decreased
within LPS+HI+IL-1Ra—compared to LPS+HI—affected
Fig. 3 Effect of IL-1Ra on neuronal morbidity and mortality of LPS+HI exposed pups. IL-1Ra decreased the percentage of mortality of pups (all the mortality
of rats occurred during hypoxia, between 1 and 1 h 30 min of hypoxia) (a) and the right hemisphere percentage of tissue loss in forebrains exposed to
LPS+HI (b). Macroscopic view of brain damage at P20 by H&E stained on coronal sections of pup exposed to LPS+HI ± IL-1Ra (c). Core lesions are indicated
by asterisks, and penumbra lesions are indicated by P. These lesions were reduced by IL-1Ra treatment. Error bars represent means ± SEM, scale
bar = 50 μm, six to eight animals per condition, unpaired t test with Welch correction, * p ≤ 0.05, *** p ≤ 0.001. Abbreviations: H&E hematoxylin
and eosin
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IL-1Ra administration, the proportion of arginase 1
(Arg1)-positive microglia/macrophages—i.e., M2 polarized
macrophages—significantly rose within LPS+HI+IL-1Ra-
compared to LPS+HI-exposed forebrains (Fig. 7c, g).
Under IL-1Ra, brain macrophage/microglia bore a quies-
cent ramified morphology compared to an activated
amoeboid morphology in the absence of IL-1Ra
(Fig. 7d, e). Thus, following LPS+HI aggression, IL-
1Ra shifted from M1 towards M2 phenotype, i.e.,
towards non-inflammatory and possibly neuroprotec-
tive macrophagic/microglial polarization [21]. The in-
duction of an IL-1β-driven macrophage chemokine
synthesis, namely MCP-1, was also assessed. A signifi-
cant rise of MCP-1 was observed following LPS+HI
exposure (Fig. 7h, i). IL-1Ra decreased the proportion
of cells expressing MCP-1 in neocortical, WM, and
striatal areas at 4 h post-HI (Fig. 7h) but the global
quantification of MCP-1 expressed within the lesioned
cerebral hemisphere did not differ between LPS+HIvs LPS+HI+L-1Ra conditions (Fig. 7i). This is likely
due to unbalanced intra- vs extra-cellular distribution
of MCP-1 depending on IL-1Ra concentration with
an overall lack of impact of IL-1Ra on macrophagic/
microglial density (Fig. 7a) in cortical and subcortical
affected areas (Fig. 7a).
Role of neuronal MMP-9 in LPS+HI-induced neurotoxicity
Among IL-1β-induced effectors of BBB disruption and
neural cell death, MMP-9 has been shown to be particu-
larly important [22]. Forebrains submitted to LPS+HI
showed a rise in MMP-9 production compared to Ctl at
48 h post-HI (Fig. 8a, b). Sixty percent of cortical neu-
rons were MMP-9 positive compared to a mere 1 %
under Ctl conditions (Fig. 8c). All MMP-9 positive cells
were NeuN positive (Fig. 8d) in cortical and deep gray
neurons, whereas no double labeling was observed
between MMP-9 and astroglial (GFAP) or macrophage/
microglial (Iba1) cell markers (data not shown). MMP-9
expression within the LPS+HI exposed brain was fully
Fig. 4 Effect of IL-1Ra on motor behavior of LPS+HI-exposed rats at P14 and P120. IL-1Ra decreased the circling score of animals 48 h after the
exposition to LPS+HI (a). At P120, IL-1Ra decreased the distance traveled in the open field (b), right/left ratio in Turning in Alley (c), and latency to
upswing (d) in elevated body swing tests of rats exposed to LPS+HI. Error bars represent means ± SEM, ten to twenty animals per conditions, unpaired
t test with Welch correction, * p≤ 0.05, *** p≤ 0.001. Abbreviations: m meter, sec second
Fig. 5 Expressions of NLRP1 and NLRP3 in neocortical neurons. IF staining of co-localizing NeuN+NLRP1+ neurons (arrowheads) in the neocortex
at P12 in control rats (a). IF staining of co-localizing Iba1+NLRP3+ macrophage/microglia (arrowheads) in the neocortex at P40 in control rats (b).
Scale bar = 10 μm, three to four animals per conditions, unpaired t test with Welch correction, ** p ≤ 0.01, **** p≤ 0.0001. Abbreviations: NLRP
nod-like receptor protein, NeuN neuronal nuclei, Iba-1 ionized calcium-binding adapter molecule 1
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Fig. 6 Effects of IL-1Ra on CINC-1 chemokine and PMN infiltration in LPS+HI-exposed brains. Decreased total cell percentage of PMN infiltration
with IL-1Ra in the right frontoparietal neocortex at 48 h after LPS+HI (a). IL-1Ra prevented PMN (arrowhead) infiltration (IHC staining) in the infarcted
neocortex of LPS+HI-exposed rats (b). Decreased relative expression of CINC-1 in the brain of LPS+HI+IL-1Ra-exposed rats compared to LPS+HI at 4 h
(c). IL-1Ra decreased the titer (ELISA) of CINC-1 (pg/mg) within the right cerebral hemisphere at 4 and 24 h after LPS+HI (d). IHC of CINC-1 in the right
frontoparietal neocortex 4 h after LPS+HI ± IL-1Ra (e). Error bars represent means ± SEM, scale bar= 10 μm, four to six animals per conditions, unpaired
t test with Welch correction, * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001, **** p≤ 0.0001. Abbreviations: PMN polymorphonuclear neutrophils, CINC-1 cytokine-
induced neutrophil chemoattractant 1; WM white matter
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MMP-9 inhibitor administration exerted a protective
effect on both components of ischemic brain injury,
namely penumbra and core (Fig. 8e, f ). The level of the
protective effect of the MMP-9 inhibitor was identical to
that of hrIL-1Ra in both core and penumbra lesions of
the forebrain (Fig. 8e), meaning that IL-1β and MMP-9
are likely interconnected molecules from the same neu-
roinflammatory cascade.
Impact of IL-1Ra on cell death mechanisms
LPS+HI acted differently on cell death pathway acti-
vations depending on forebrain areas. In the LPS+HI-
exposed compared to Ctl neocortex, RIP-3-associatednecroptosis occurred at 4 h post-HI (Fig. 9a), whereas
no change in activated caspase-3 was detected at 4,
24 (data not shown), or 48 h post-HI (Fig. 9a, b).
Within the LPS+HI-exposed compared to Ctl stri-
atum, both RIP-3 (at 4 h post-HI) and activated
caspase-3 (at 48 h post-HI) were involved in LPS+HI-
induced neural cell death (Fig. 9a, b). In the LPS+HI-
exposed vs Ctl WM, RIP-3-associated necroptosis was
activated at 4 h post-HI (Fig. 9a, b) whereas activated
caspase-3 expression was not affected at 4, 24, and
48 h post-HI. IL-1Ra curbed the expression of acti-
vated caspase-3 in the LPS+HI-exposed striatum as
well as that of RIP-3-associated necroptosis in the
LPS+HI-exposed neocortex and WM (Fig. 9a, b).
Fig. 7 (See legend on next page.)
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Follow-up to P120 revealed no mortality following
the hypoxic phase in rats exposed to sole LPS+HI vsLPS+HI+IL-1Ra. Beyond those above mentioned, we
observed no particular clinical manifestation between
animals exposed to LPS+HI vs LPS+HI+IL-1Ra. Since
(See figure on previous page.)
Fig. 7 Effects of IL-1Ra on MCP-1 chemokine, M1/M2 microglia/macrophages infiltration, and polarization in LPS+HI-exposed brains. Total cell
percentages of Iba1+ cells in LPS+HI ± IL-1Ra-exposed frontoparietal cortex, white matter, and caudate putamen nuclei of the right hemisphere at
48 h (a). Decreased relative expression of iNOS (IHC staining) in the right frontoparietal neocortex of LPS+HI+IL-1Ra-exposed rats at 48 h compared to
LPS+HI (b). Increased Iba1+ cell percentage of Iba1+Arg1+ cells in the frontoparietal WM of the right hemisphere of LPS+HI+IL-1Ra-exposed rats at
48 h (c). IL-1Ra prevented macrophage activation by keeping them in a ramified morphology (arrows), instead of amoeboid (activated) morphology
(arrowheads), as shown by CD68 staining (IHC) at 48 h after LPS+HI (d). Change in the CD68+ cell percentage of activated/quiescent macrophages in
LPS+HI ± IL-1Ra-exposed brains (e). IL-1Ra prevented IHC staining of iNOS at 48 h after LPS+HI (f). IL-1Ra increased IF staining of Iba1+Arg1+ microglia/
macrophages (arrowhead) in the frontoparietal white matter of the right hemisphere at 48 h (g). IL-1Ra decreased relative expression of MCP-1 (IHC staining) in
the brain of LPS+HI-exposed rats at 4 h (h). MCP-1 titer (pg/mg) measured by ELISA within the right cerebral hemisphere at 4 and 24 h after LPS+HI (i). Error
bars represent means ± SEM, scale bar=10 μm, four to six animals per conditions, unpaired t test with Welch correction, * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001,
**** p ≤ 0.0001. Abbreviations: Iba1 ionized calcium-binding adapter molecule 1, Arg1 arginase 1, iNOS inducible nitric oxide synthase, MCP-1
monocyte chemotactic protein 1, CD68 cluster of differentiation 68, WM white matter
Fig. 8 Effect of IL-1Ra on MMP-9 expression in LPS+HI-exposed brains. IL-1Ra decreased the titer of total MMP-9 (ng/mg) measured by ELISA
within the right cerebral hemisphere at 48 h after exposure to LPS+HI (a). This decrease was confirmed by immunostaining of total MMP-9 expression
at 48 h in LPS+HI ± IL-1Ra-exposed brains in gray and white matters (b). The proportion of double positive NeuN+MMP-9+ among NeuN+ neurons (d)
from the frontoparietal neocortex of the right hemisphere at 48 h after LPS+HI was not affected by IL-1Ra exposures (c). Decreased right hemisphere
percentage of tissue loss in LPS+HI-exposed forebrains treated by IL-1Ra or by SB-3CT at P20 (e). SB3CT prevented the extent of brain lesions after LPS
+HI exposure in the same measure as IL-1Ra (f). Core of the lesion was indicated by asterisks. Error bars represent means ± SEM, scale bar = 10 μm, four
to six animals per conditions, unpaired t test with Welch correction, * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001, **** p≤ 0.0001. Abbreviations: MMP9 matrix
metallo-protease 9, NeuN neuronal nuclei, WM white matter
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Fig. 9 Effect of IL-1Ra on neuronal death effectors in LPS+HI-exposed brains. Decreased relative expression (IHC staining) of RIP-3 within right
frontoparietal neocortex, but not in the WM and caudate putamen nuclei exposed to LPS+HI+IL-1Ra compared to LPS+HI at 4 h post-HI
(a). Following LPS+HI insults, IL-1Ra decreased the percentage of caspase-3+ cells (IHC staining) in the striatum at 48 h post-HI (b). Error
bars represent means ± SEM, four to six animals per conditions, unpaired t test with Welch correction, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
Abbreviations: RIP-3 receptor interacting protein 3, WM white matter
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no significant difference in central body temperature
between animals from the Ctl vs LPS+HI vs LPS+HI+IL-
1Ra experimental groups (Fig. 10a). This means that the
neuroprotective and anti-inflammatory effects we ob-
served during—and following—IL-1Ra administration was
not due to hypothermia. IL-1Ra did not affect the weight
of LPS+HI animals compared to Ctl at P15, P20, P25, and
P100 (Fig. 10b).
Discussion
Our key findings are that IL-1β and MMP-9 from
neuronal origin play a central role in LPS+HI-induced
injury of the newborn brain. Neuronal IL-1β might be
up-regulated both via mRNA synthesis and NLRP1Fig. 10 Effect of IL-1Ra on the temperature and the weight growth of LPS
body weight (b) of LPS+HI-exposed rats. Error bars represent means ± SEM,
correction. Error bars represent means ± SEM. Abbreviations: °C degree Celsinflammasome activation. IL-1Ra (peripherally adminis-
tered) reaches the brain and interacts directly with
neuronal cells to interfere with IL-1β mRNA and
protein and MMP-9 synthesis. Neuronal IL-1β up-
regulates chemokines (CINC-1, MCP-1), as well as
other pro-inflammatory and neurotoxic mediators,
namely iNOS and MMP-9. MMP-9—likely in combin-
ation with iNOS—might participate to disrupt the BBB
[23, 24]. BBB leaks, combined to CINC-1 up-regulation,
would facilitate PMN infiltration within the brain. IL-
1β modulates macrophages’ polarization since its
blockade maintains the M1/M2 balance towards an
M2 anti-inflammatory and neuroprotective phenotype.
Finally, IL-1β activates neural cell death pathways,
namely RIP-3-associated necroptosis and caspase-3-+HI-exposed rats. IL-1Ra had no effect on central temperature (a) and
eight to sixteen animals per conditions, unpaired t test with Welch
ius, g gram
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IL-1β and MMP-9 contribute to neuronal self-injury and
that their blockade curbs this effect.
Pro-IL-1β is cleaved by a macromolecular complex
called the inflammasome for IL-1β secretion to occur
[25]. Stimuli triggering inflammasome assembly and ac-
tivation, within LPS+HI-exposed neurons, could be
damage-associated molecular patterns (DAMPs) release
due to the release of endogenous molecules following
cellular damage such as that induced by LPS+HI [20].
Inflammasome-dependent IL-1β processing relies on
distinct NLRs that respond to the intracellular milieu
and trigger inflammasome assembly [20]. We showed
that NLR expression within neural cells is developmen-
tally regulated, NLRP1 being expressed at P12 (but not
P1) within neurons. NLRP3 however was undetected in
the P1 or P12 immature brain and only expressed later.
Thus, exposure to LPS+HI might release DAMPs within
the cytoplasm of neurons leading to exacerbated activa-
tion of IL-1β, through NLRP1 inflammasome activation.
In addition, LPS might interact with TLR-4 to increase
the synthesis of IL-1β via NF-κB activation. Such ability
of neurons to produce IL-1β mRNA and protein has also
been reported by others in rodents subjected to either HI,
traumatic or excitotoxic brain injury [26–28]. Thus,
exposure to LPS+HI at a specific term-like stage of brain
development may lead to an autocrine/paracrine loop of
neuronal self-injury, mediated by IL-1β and subsequent
neurotoxic mechanisms such as IL-1β-induced MMP-9
and NO production and/or IL-1β exacerbation of excito-
toxic damage [25, 29]. Consistent with such mechanisms,
IL-1Ra blockade of the IL-1β signaling pathway decreases
the extent of LPS+HI-induced brain injury. Another
mechanism whereby IL-1Ra limits LPS+HI-induced injury
appears to be by preventing the IL-1β-induced M1
polarization of macrophages [30].
MMP-9 competitive inhibitor shrunk the size of
LPS+HI-induced brain lesions to a same extent as IL-
1Ra treatment. MMP-9 induces cell death via anoikis,
an integrin-mediated form of caspase-3-induced apop-
tosis [31]. When the cell loses its tether to the extra-
cellular matrix, anoikis is induced via caspase-9 and
the apoptosome [31]. Such a cell death mechanism is
relevant to our findings showing LPS+HI-induction of
activated caspase-3 and subsequent neuronal cell
death—that is preventable by MMP-9 inhibitor treat-
ment. MMP-9 also alters the BBB by degrading the
lamina of intra-cerebral blood vessels. Such disruption
would enable pro-inflammatory and/or neurotoxic
mediators to leak through the BBB and thus increase
the extent of intra-cerebral lesions. NO is also known
for its deleterious effects on the BBB [32]. Causing a
rise of expression of iNOS in LPS+HI brains, together
NO and MMP-9 could alter the BBB permeability.We also observed cerebral expression of TNFα fol-
lowing LPS+HI exposure (data not shown). It is known
that TNFα—the synthesis of which is induced by IL-
1β—mediates receptor-interacting-protein (RIP) kinase-
dependent necroptosis [33]. RIP-1 and -3 associate with
TNF receptor-associated death domain (TRADD) and
migrate to the mitochondria [33]. This complex re-
leases reactive oxygen species (ROS) and DNAses from
the mitochondria, inducing necroptosis [33]. Accord-
ingly, our findings show that RIP-3 expression is
increased after LPS+HI. IL-1β-induced MMP-9 (see
Fig. 8) also activates necroptosis via FAS-FAS ligand
(FASL) interaction through FAS-associated death
domain (FADD) [31, 33]. RIP kinases associated with
FADD, as well as TRADD, activate necroptosis [33].
Either of these cell death mechanisms might be in-
volved in LPS+HI-induced brain damage in term NE.
In human NE, the only current treatment known to be
efficient is hypothermia [34, 35]. Hypothermia acts on
penumbra but not core lesions in animal models of neo-
natal HI encephalopathy [34]. In human NE, hypothermia
imparts only partial neuroprotection. IL-1Ra, which acts
on both, may one day afford additional neuroprotective
benefits to hypothermia [34, 35]. However, this needs to
be tested in future clinical trials.
Conclusion
Interfering with neuronal IL-1β signaling damped neuro-
inflammation of core and penumbra brain lesions—switch
from M1 to M2 macrophage/microglial polarization and
decreased PMN infiltration as well as iNOS and chemo-
kine productions—and alleviated motor impairments.
Neuroprotective treatments available against NE are very
limited. They mainly consist in symptomatic supportive
care and in hypothermia that leave about 50 % of the pa-
tients affected by moderate or severe neurobehavioral
sequelae. rhIL-1Ra, possibly combined to hypothermia,
might be a promising translational option to prevent the
severe neurodisabilities complicating NE.
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